Sight Sciences Presents Q3 Revenue Growth of 25% to $24.9 Million

PUBT · 19h ago
Sight Sciences Presents Q3 Revenue Growth of 25% to $24.9 Million
  • Sight Sciences reported third-quarter 2026 revenue of $24.9 million, up 25% year over year.
  • Quarterly cash usage fell 74% to $2.4 million.
  • Year-to-date revenue rose 19% to $68 million; adjusted operating expenses declined 2% to $67.5 million.
  • Interventional glaucoma year-to-date revenue increased 7% to $60.1 million.
  • Interventional dry eye year-to-date revenue reached $7.9 million, compared with $0.9 million a year earlier.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Sight Sciences Inc. published the original content used to generate this news brief on November 04, 2026, and is solely responsible for the information contained therein.